| Literature DB >> 32876794 |
Jihene Lachheb1, Houssem Mastour2, Jihene Nsiri2, Khaled Kaboudi3, Imed Choura4, Faten Ammouna2, Abdelkader Amara3, Abdeljelil Ghram2.
Abstract
Marek's disease (MD) is a contagious avian viral disease that is responsible for large economic losses to farmers. The disease is caused by Marek's disease virus (species Gallid alphaherpesvirus 2), which causes neurological lesions, immune suppression, and tumor proliferation of lymphoid cells that invade a large number of organs and tissues. Despite widespread vaccination, Marek's disease virus (MDV), has shown a continuous increase in its virulence and has acquired the ability to overcome immune responses induced by vaccines. In the present study, the oncogenic serotype MDV-1 was detected by real-time PCR in DNA samples extracted from organs developing tumor infiltrations. Identification of the pathotype based on a 132-bp tandem repeat and sequencing and phylogenetic analysis of the Meq gene and its encoded protein allowed classification of the isolated viruses as "very virulent", with two new and unique mutations in the Meq gene resulting in amino acid substitutions. Sequencing of pp38, vIl-8, UL1 and UL44 genes did not reveal any new mutations that were characteristic of the Tunisian isolates or correlated with virulence. These results raised concerns about the ability of HVT and CVI988 vaccines, which are currently used in Tunisia and other countries, to protect chickens against highly virulent virus strains.Entities:
Mesh:
Substances:
Year: 2020 PMID: 32876794 PMCID: PMC7547972 DOI: 10.1007/s00705-020-04790-5
Source DB: PubMed Journal: Arch Virol ISSN: 0304-8608 Impact factor: 2.574
Summary of the data samples
| Sample | Bird number | Type | Age (weeks) | Onset of symptoms (week) | Mortality (%) | Origin |
|---|---|---|---|---|---|---|
| TN 1013/16 | 90 | Broiler | 18 | 7th | 11.1 | Cherfech-Ariana |
| TN 1014/16 | 40 | Broiler | 6 | 4th | 30 | Borjyoussef-Ariana |
Fig. 1Phylogenetic tree of GaHV-2 based on the Meq gene. The tree was constructed using maximum-likelihood algorithm implemented in MEGA 6.0.6 with 1000 bootstrap replicates. Tunisian isolates are indicated by red diamonds
Number of PPPP signatures and proline percentage in different GaHV-2 pathotypes
| Isolate | Country | Accession number | Size of Meq (aa) | Proline % | Number of PPPP repeats | Pathotype |
|---|---|---|---|---|---|---|
| CVI988 | Netherlands | DQ534538 | 399 | 23.3 | 8 | AttMDV |
| JM/102 W | United States | DQ534539 | 399 | 23.1 | 6 | vMDV |
| MPF57 | Australia | EF523771 | 398 | 22.9 | 5 | vMDV |
| RB1B | United States | AY243332 | 339 | 21.5 | 5 | vvMDV |
| Md5 | United States | AF243438 | 339 | 21.3 | 4 | vvMDV |
| TN1013/16 | Tunisia | MK041219 | 339 | 21.18 | 4 | vvMDV |
| TN1014/16 | Tunisia | KY113150 | 339 | 21.18 | 4 | vvMDV |
| 648A | United States | AY362725 | 339 | 20.9 | 2 | vv + MDV |
| GaHV-2/Italy/Ck/855/17 | Italy | MK139678 | 298 | 19.4 | 2 | – |
| GaHV-2/Italy/Ck/674/16 | Italy | MK139667 | 339 | 21.18 | 4 | – |
Fig. 2Amplification profile of the 132-bp tandem repeat on a 1.5% agarose gel. MT, 100-bp size marker; T + , vaccine (CVI988 Rispens); 1, sample TN1013/16; 2, sample TN1014/16; T-, negative control